Application
Figure 1:Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)Application
Figure 2:Western blot analysis using CD267 mAb against human CD267 (AA: extra 1-165) recombinant protein. (Expected MW is 44.5 kDa)Application
Figure 3:Western blot analysis using CD267 mAb against HEK293 (1) and CD267 (AA: extra 1-165)-hIgGFc transfected HEK293 (2) cell lysate.| Product Name | CD267 |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | TNFRSF13B; CVID; RYZN; TACI; CVID2; IGAD2; TNFRSF14B |
| Immunogen | Purified recombinant fragment of human CD267 (AA: extra 1-165) expressed in E. Coli. |
| Clonality | Monoclonal |
|---|---|
| Host Species | Unknow |
| Tested Applications | WBICC/IF |
| WB:1:250~1:1000 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|
| Species Reactivity | Human |
| Alternative Names | TNFRSF13B CVID RYZN TACI CVID2 IGAD2 TNFRSF14B |
|---|---|
| Molecular Weight(MW) | 31.8kDa |
| Entrez Gene | 23495 |
|---|
Application
Figure 1:Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)
Application
Figure 2:Western blot analysis using CD267 mAb against human CD267 (AA: extra 1-165) recombinant protein. (Expected MW is 44.5 kDa)
Application
Figure 3:Western blot analysis using CD267 mAb against HEK293 (1) and CD267 (AA: extra 1-165)-hIgGFc transfected HEK293 (2) cell lysate.| Application Notes | WB:1:250~1:1000 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|---|
| Form | Purified antibody in PBS with 0.05% sodium azide |
|---|---|
| Storage Instructions | 4℃; -20℃ for long term storage |
